Avanos Medical Inc’s filing revealed that its SVP, Chief Commercial Officer Holbrook Kerr unloaded Company’s shares for reported $0.11 million on Mar 06 ’25. In the deal valued at $15.25 per share,7,000 shares were sold. As a result of this transaction, Holbrook Kerr now holds 82,047 shares worth roughly $1.06 million.
Then, Holbrook Kerr bought 7,000 shares, generating $106,780 in total proceeds.
KeyBanc Capital Markets downgraded its Avanos Medical Inc [AVNS] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Stephens also remained covering AVNS and has decreased its forecast on August 04, 2021 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Barclays revised its rating on April 13, 2020. It rated AVNS as “an Equal weight” which previously was an “an Underweight”.
Price Performance Review of AVNS
On Tuesday, Avanos Medical Inc [NYSE:AVNS] saw its stock jump 2.14% to $12.91. Over the last five days, the stock has gained 3.69%. Avanos Medical Inc shares have fallen nearly -18.91% since the year began. Nevertheless, the stocks have fallen -35.96% over the past one year.
How much short interest is there in Avanos Medical Inc?
A steep rise in short interest was recorded in Avanos Medical Inc stocks on 2025-05-30, growing by 0.43 million shares to a total of 1.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 1.13 million shares. There was a rise of 27.55%, which implies that there is a positive sentiment for the stock.
